STAGE 06 · CLINICAL & REGULATORY
Generate clinical evidence and secure authorization
Build an evidence package that supports the intended indication, labeling, authorization pathway, and clinical adoption.
RECOGNIZE THE STAGE
How to know you are here
The pivotal or confirmatory evidence question is defined
Endpoints, population, and claims are aligned
Regulatory interactions and submission planning are active
READINESS LENSES
What must be managed together
Clinical protocol, endpoints, statistical plan, monitoring, data quality, and claim-supporting results.
510(k), De Novo, PMA, or relevant international pathway; IDE and IRB may be required.
Series A/B · strategics · larger grants. Often $5M–$50M+.
ACTION PLAN
Priorities for the next 90 days
- 01
Align the clinical question with labeling and commercial claims
- 02
Confirm endpoints, population, sample size, and operational feasibility
- 03
Prepare IDE, IRB, monitoring, and data-management plans as needed
- 04
Build the submission and deficiency-response strategy early
BEFORE YOU ADVANCE
Required outputs
- Clinical evidence plan and protocol
- Regulatory submission package
- Labeling and claims matrix
- Clinical adoption and publication plan
WATCH FOR
Common failure modes
- A study that answers the wrong question
- Endpoints that are not meaningful to regulators or buyers
- Clinical operations that compromise data quality or timeline
THE DECISION GATE
Will the complete evidence package support authorization, labeling, reimbursement, and adoption?
Do not advance because time or money has been spent. Advance when the evidence supports the decision.
NEED A COMPANY-SPECIFIC ROADMAP?
Turn this orientation into a milestone plan.
SECUIA can connect product, evidence, regulatory, usability, and financing decisions around your actual technology.
Call SECUIA